These Analysts Revise Their Forecasts On Intuitive Machines Following Q2 Results

Intuitive Machines reported Q2 revenue of $206.17M, up from $50.31M YoY but below the $220.76M estimate, while GAAP diluted EPS was a -$0.29 loss versus a -$0.07 loss expected. The company affirmed full-year revenue guidance of $900M-$1B versus a $934.01M estimate and reiterated expectations for positive adjusted EBITDA. Despite pre-market shares rising 5.3% to $18.49, analysts cut price targets (Stifel $32→$26; Cantor $43→$32) following the earnings print.

Analysis

LUNR is still being priced as an execution story, not a revenue story. In this phase, the market cares less about top-line growth than whether milestones convert into clean margins and working capital; an earnings miss like this raises the probability that future quarters stay lumpy even if the annual guide is technically intact. The equity can support a high multiple only if investors believe the backlog is high-quality and collectible, so any hint of recognition slippage or cost creep can compress the multiple quickly.

The immediate read-through is to the broader space-tech complex: better-capitalized names with more diversified revenue streams should screen as relatively safer, while pure-play lunar exposure gets a higher risk discount. If management has to spend more to de-risk execution, suppliers and subcontractors may actually benefit near term, but the company itself may sacrifice operating leverage, which is the real driver of upside from here. The premarket bounce looks more like a positioning squeeze than a durable re-rating unless the next contract cadence and cash conversion visibly improve.

Contrarian view: consensus may be underweighting the value of reaffirmed full-year guidance in a lumpy government-contract business, where one quarter is a noisy data point. But that same consensus may be too forgiving on how fragile the margin bridge is at this scale; if the next 1-3 months do not bring a material backlog-to-billings acceleration, the stock likely fades back toward a lower-quality multiple. The key falsifier is not another revenue beat alone, but a sustained improvement in gross margin and operating cash flow that proves the company can scale without dilution or further execution slips.

Key Decisions for Investors

• Do not chase the premarket pop in LUNR; wait 1-3 sessions for post-earnings positioning to settle, then consider a tactical fade only if the stock loses the opening gain and reclaims no better than the $18 area. Risk/reward improves if the market starts discounting the EPS miss as non-recurring.
• Relative-value: long RKLB / short LUNR over the next 1-3 months as a quality-vs-execution pair. The thesis is that capital rotates toward the cleaner balance sheet and less single-program-dependent story if lunar execution remains uneven; invalidate if LUNR shows a materially better cash conversion trend or a major contract award.
• If you want upside exposure, use defined-risk calls rather than common: buy a 1-2 month call spread on LUNR only on a pullback, not strength. The trade works only if backlog/newsflow drives a second leg higher; if the stock stalls below the analyst target resets, theta will win quickly.
• Set an alert for the next quarterly gross margin and operating cash flow print. If management cannot show margin expansion despite higher revenue, treat the current multiple as fragile and prepare for a 15-25% de-rating over 3-6 months.